Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTA, Biodentine and PRF for Pulpotomy in Pulpitis
NCT04773886Phase 4Completed
- Sponsor
- Maharishi Markandeshwar University
- Start
- Feb 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 4 trial of Biodentine, platelet rich fibrin in irreversible pulpitis, sponsored by Maharishi Markandeshwar University. Started Feb 2020; status: completed.
02
Drugs
Biodentineplatelet rich fibrin
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT04773886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04773886.